6 posts in this category
Products marketed as "natural GLP-1s" and peptide supplements are everywhere. Here is what the science says and how to protect yourself.
Major GLP-1 and obesity drug trials are finishing in 2027. Here’s what they’re studying and what it could mean for access and affordability.
Peer-reviewed research shows GLP-1 medications do not meaningfully increase cancer risk. Here’s what large human studies say in 2026.
Learn what orforglipron is, how this daily oral GLP-1 works, where the research stands now, and what to watch for as it moves toward FDA review.
Learn how FDA-approved GLP-1 medications like Wegovy, Ozempic, Mounjaro, and Zepbound work—and what to know about compounded and next-gen options.
Learn what microdosing GLP-1s really means, what’s known, what’s not, and key questions to ask your doctor before considering it.
